Infliximab associated new-onset psoriasis.

David R. Adams, Tamy Buckel, Jennifer A. Sceppa

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.

Original languageEnglish (US)
Pages (from-to)178-179
Number of pages2
JournalJournal of drugs in dermatology : JDD
Volume5
Issue number2
StatePublished - Feb 2006

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint Dive into the research topics of 'Infliximab associated new-onset psoriasis.'. Together they form a unique fingerprint.

Cite this